Screener
Teladoc Health TDOC Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Teladoc Health in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The source filing: Teladoc Health’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 9:54 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001477449-26-000038
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Total liabilities | 1,448,517 | 1,472,594 |
| Commitments and contingencies (Note 14) | ||
| Stockholders’ equity: | ||
| Common stock, $0.001 par value; 300,000,000 shares authorized; 181,649,591 shares and 178,315,400 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | 182 | 178 |
| Additional paid-in capital | 17,876,827 | 17,850,478 |
| Accumulated deficit | (16,532,967) | (16,430,222) |
| Accumulated other comprehensive loss | (33,934) | (34,728) |
| Total stockholders’ equity | 1,310,108 | 1,385,706 |
ITEM 1. Financial Statements
FAQ
- What is Teladoc Health's common stock, par value (in dollars per share)?
- Teladoc Health (TDOC) reported common stock, par value (in dollars per share) of $0 in Q2 2026.
- How has Teladoc Health's common stock, par value (in dollars per share) changed year-over-year?
- Teladoc Health's common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Teladoc Health's common stock, par value (in dollars per share)?
- Over 3 years (2022 to 2025), Teladoc Health's common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.
Ask your AI about Teladoc Health's common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude